US Edition[Opinion] Johnson & Johnson launches The 3rd Opinion in Asia Pacific: a new term to elevate the patient voice in the lung cancer treatment journey
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.2 Articles
2 Articles
Johnson & Johnson Launches ‘The 3rd Opinion’ in Asia Pacific
SINGAPORE - Media OutReach Newswire - 1 August 2025 - Today, on World Lung Cancer Day, Johnson & Johnson announced the launch of The 3rd Opinion, the patient's own opinion, a new term that seeks to elevate the patient voice and transform the treatment journey of lung cancer across Asia Pacific by enhancing shared decision making. With significant scientific advancements and more lung cancer treatments becoming available, it is essential for pati…
Coverage Details
Total News Sources2
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
